Long Christopher J, Ginsberg Jill P, Kolon Thomas F
Division of Urology, Children's Hospital of Philadelphia, Department of Surgery (Urology), Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Division of Oncology, Children's Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Division of Urology, Children's Hospital of Philadelphia, Department of Surgery (Urology), Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Division of Oncology, Children's Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Urology. 2016 May;91:190-6. doi: 10.1016/j.urology.2015.10.047. Epub 2016 Jan 11.
Advancements in oncologic therapy have increased long-term survival rates for children with childhood cancers. As survival has increased, the secondary effects of treatment have come into focus for patients and family. Infertility preservation in prepubertal children is a particularly difficult task as options are limited compared to adult counterparts with mature gametes.
A systematic review of the published literature was conducted using keywords relevant to fertility preservation in the pediatric population undergoing oncologic treatment.
We review the impact of cancer therapy upon gonadal function and identify the risk factors for future infertility in the prepubertal population. Treatment modifications that could modify the degree of potential damage to reproductive organs yet maintain oncologic principles were highlighted. Pubertal males and females have the opportunity to donate mature sperm or oocytes as do their adult counterparts; however, for the prepubertal child this is not the case. The options for these patients are considered investigational at this point and center on testicular tissue cryopreservation in males and oophorectomy vs ovarian cortical tissue cryopreservation in females.
Infertility is an unfortunate side effect of oncologic treatment. Options are limited in the prepubertal population but tissue preservation and potential fertility should be discussed with all at-risk patients and their parents.
肿瘤治疗的进展提高了儿童癌症患者的长期生存率。随着生存率的提高,治疗的继发效应已成为患者及其家庭关注的焦点。与具有成熟配子的成年患者相比,青春期前儿童的生育力保存是一项特别困难的任务,因为选择有限。
使用与接受肿瘤治疗的儿科人群生育力保存相关的关键词,对已发表的文献进行系统综述。
我们回顾了癌症治疗对性腺功能的影响,并确定了青春期前人群未来不孕的风险因素。强调了可以改变对生殖器官潜在损害程度但仍坚持肿瘤学原则的治疗调整方法。青春期男性和女性与成年男性和女性一样有机会捐献成熟精子或卵子;然而,青春期前儿童则不然。目前,这些患者的选择被视为试验性的,主要集中在男性的睾丸组织冷冻保存以及女性的卵巢切除术与卵巢皮质组织冷冻保存。
不孕是肿瘤治疗的一个不幸的副作用。青春期前人群的选择有限,但应与所有有风险的患者及其父母讨论组织保存和潜在生育力问题。